hVIVO keen to expand challenge trials presence into new indications - Proactive Investors UK
hVIVO keen to expand challenge trials presence into new indications Proactive Investors UK
hVIVO PLC (LON:HVO) has developed a human-based clinical trial platform to accelerate drug and vaccine development in respiratory and infectious diseases ...
Comments
Post a Comment